[Form 4] Medpace Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Mohawk Industries, Inc. (MHK) has filed a Form 144 announcing a proposed insider sale.

• Shares to be sold: 16,000 common shares.
• Estimated proceeds: $1,933,046.71.
• Approximate sale date: 28 Jul 2025.
• Broker: TD Securities (USA) LLC, NYSE execution.
• Shares outstanding: 62,520,000; sale equals roughly 0.03 % of total.
• Acquisition history: Shares originally received on 25 Feb 1994 via company disbursement.
• No other insider sales by this filer reported in the past three months.

The notice fulfills Rule 144 requirements and relates to a quantitatively small transaction; it does not disclose any operational or financial data about Mohawk. Impact on the company’s capital structure and market liquidity is expected to be immaterial, though investors tracking insider sentiment may note the filing.

Positive

• None.

Negative

• Insider intends to sell 16,000 shares ($1.93 m), which, while small in percentage terms, could be interpreted by some investors as a modestly bearish signal.

Insights

Financial Analyst

TL;DR: Minor Form 144 filing—16k MHK shares (~$1.9 m) to be sold, only 0.03% of float; negligible structural impact.

The proposed sale involves 16,000 common shares against a base of 62.5 m, making the transaction statistically insignificant to both float and daily trading volume. The shares were acquired in 1994, suggesting long-held, legacy ownership rather than short-term profit taking. No additional insider sales are reported for the past quarter, and the filing contains no forward-looking statements or financial metrics. As such, the event is best viewed as routine compliance with Rule 144 rather than a signal of corporate outlook. For portfolio managers, this merits monitoring but not portfolio action unless aggregated with broader insider activity trends.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

GEIGER JESSE J

(Last) (First) (Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI OH 45227

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/24/2025		M		41,801	A	$107.93	78,304	D
Common Stock	07/24/2025		S(1)		41,801	D	$453.11(2)	36,503	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$107.93	07/24/2025		M			41,801	(3)	02/28/2026	Common Stock	41,801	$0	0	D

Explanation of Responses:

1. The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

2. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $450.039 to $457.992. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

3. The option vested in full on February 28, 2020.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Jesse J. Geiger	07/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Mohawk Industries (MHK) shares are being sold under the Form 144?

The filing covers 16,000 common shares.

What is the estimated market value of the planned MHK share sale?

The aggregate market value is $1,933,046.71.

When is the proposed sale of Mohawk Industries shares expected to occur?

The approximate sale date listed is 28 July 2025.

What percentage of Mohawk Industries’ outstanding shares does this sale represent?

It equals roughly 0.03 % of the 62.52 million shares outstanding.

Which broker is facilitating the sale disclosed in the Form 144?

The broker named is TD Securities (USA) LLC, executing on the NYSE.